Abstract The efficacy of Stereotactic Body Radiation Therapy (SBRT) in early-stage non-
small cell lung cancer for severely hypofractionated schedules is clinically proven. Tumour …

Abstract Background. The Cancer Risk Management Model (CRMM) was used to estimate
the health and economic impact of introducing stereotactic ablative radiotherapy (SABR) for …

Purpose: Technologic developments have made radiation therapy (RT) more effective and
have introduced new treatment options, such as stereotactic ablative radiation therapy …

Objective The objective of this study was to assess the role of stereotactic body radiotherapy
(SBRT) in the treatment of distantly recurrent, oligometastatic gynecological cancer. Methods …

Background Stereotactic body radiation therapy (SBRT) is standard care for patients with
inoperable early-stage non-small cell lung cancer. However, clinicians may hesitate to use …

This survey is performed to update knowledge about methods and trends in lung cancer
radiotherapy. A significant development has been noticed in radiotherapeutic techniques …

Background Previous studies have relied on international spirometry criteria to diagnose
COPD in patients with lung cancer without considering the effect lung cancer might have on …

The survival of patients presenting with early-stage non–small-cell lung cancer (NSCLC)
remains disappointing. The 5-year survival rates after an anatomic surgical resection range …

Outcomes of non-small cell lung cancer (NSCLC) patients with chronic obstructive
pulmonary disease (COPD n= 587) and interstitial lung disease (ILD n= 34) treated with …

Simple Summary Surgery or conventional radical radiotherapy are established curative
treatment options for patients with localised, stage I non-small-cell lung cancer (NSCLC) …